Phosphodiesterase 4 inhibitors, including aminoindazole and...

Details Phosphodiesterase 4 inhibitors, including aminoindazole and... Phosphodiesterase 4 inhibitors, including aminoindazole and...

2006-12-21

2010-02-02

Powers, Fiona T (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C548S362500

Reexamination Certificate

active

07655802

ABSTRACT:
PDE4 inhibition is achieved by novel compounds, e.g., aminoindazole and aminobenzofuran analogs. The compounds of the present invention are of Formulas I and II:wherein R1, R2, R3, R4, R7and R8are as defined herein.

REFERENCES:
patent: 3259623 (1966-07-01), Kober et al.
patent: 3755332 (1973-08-01), Wesley et al.
patent: 3968214 (1976-07-01), Claverie et al.
patent: 4524373 (1985-06-01), Kondo et al.
patent: 5204226 (1993-04-01), Baier et al.
patent: 5204366 (1993-04-01), Lavanish et al.
patent: 5221682 (1993-06-01), Effland et al.
patent: 5580870 (1996-12-01), Barker et al.
patent: 5591776 (1997-01-01), Cavalla et al.
patent: 5622977 (1997-04-01), Warrellow et al.
patent: 5633257 (1997-05-01), Warrellow et al.
patent: 5679696 (1997-10-01), Fenton et al.
patent: 5693659 (1997-12-01), Head et al.
patent: 5698711 (1997-12-01), Palfreyman
patent: 5710160 (1998-01-01), Guay et al.
patent: 5710170 (1998-01-01), Guay et al.
patent: 5712298 (1998-01-01), Amschler
patent: 5723460 (1998-03-01), Warrellow et al.
patent: 5728712 (1998-03-01), Montana et al.
patent: 5739144 (1998-04-01), Warrellow et al.
patent: 5776958 (1998-07-01), Warrellow et al.
patent: 5780477 (1998-07-01), Head et al.
patent: 5780478 (1998-07-01), Alexander et al.
patent: 5786354 (1998-07-01), Warrellow et al.
patent: 5798373 (1998-08-01), Warrellow et al.
patent: 5814651 (1998-09-01), Duplantier et al.
patent: 5840724 (1998-11-01), Fenton et al.
patent: 5849770 (1998-12-01), Head et al.
patent: 5859034 (1999-01-01), Warrellow et al.
patent: 5866593 (1999-02-01), Warrellow et al.
patent: 5880135 (1999-03-01), Gully et al.
patent: 5889014 (1999-03-01), Cavalla et al.
patent: 5891896 (1999-04-01), Warrellow et al.
patent: 5919937 (1999-07-01), Lynch et al.
patent: 5935966 (1999-08-01), Suto et al.
patent: 5935978 (1999-08-01), Fenton et al.
patent: 5962483 (1999-10-01), Warrellow et al.
patent: 5962492 (1999-10-01), Warrellow et al.
patent: 6040329 (2000-03-01), Marfat
patent: 6077854 (2000-06-01), Warrellow et al.
patent: 6096768 (2000-08-01), Ashton et al.
patent: 6107301 (2000-08-01), Aldrich et al.
patent: 6153630 (2000-11-01), Cavalla et al.
patent: 6162830 (2000-12-01), Connor et al.
patent: 6180650 (2001-01-01), Frenette et al.
patent: 6200993 (2001-03-01), Cote et al.
patent: 6204275 (2001-03-01), Friesen et al.
patent: 6235736 (2001-05-01), Ina et al.
patent: 6245774 (2001-06-01), Warrellow et al.
patent: 6255326 (2001-07-01), Ashton et al.
patent: 6262040 (2001-07-01), Marfat
patent: 6297264 (2001-10-01), Head et al.
patent: 6589950 (2003-07-01), Collingwood et al.
patent: 6699890 (2004-03-01), Schumacher et al.
patent: 7105530 (2006-09-01), Boloor et al.
patent: 7153871 (2006-12-01), Schumacher et al.
patent: 2002/0151566 (2002-10-01), Schumacher et al.
patent: 2003/0149052 (2003-08-01), Schumacher et al.
patent: 2004/0152902 (2004-08-01), Schumacher et al.
patent: 2004/0230072 (2004-11-01), Schumacher et al.
patent: 2005/0119225 (2005-06-01), Schumacher et al.
patent: 2005/0222207 (2005-10-01), Schumacher et al.
patent: 580519 (1933-07-01), None
patent: 0994100 (2000-04-01), None
patent: 1116711 (2001-07-01), None
patent: 2729142 (1996-07-01), None
patent: 1 337 389 (1973-11-01), None
patent: 11-189577 (1999-07-01), None
patent: 2001 011047 (2001-01-01), None
patent: 93/25517 (1993-12-01), None
patent: WO 94/02465 (1994-02-01), None
patent: 94/14742 (1994-07-01), None
patent: 94/27971 (1994-12-01), None
patent: WO 95/01338 (1995-01-01), None
patent: WO 95/04046 (1995-02-01), None
patent: WO 95/20578 (1995-08-01), None
patent: 96/21435 (1996-07-01), None
patent: WO 96 21435 (1996-07-01), None
patent: 96/23754 (1996-08-01), None
patent: 96/36620 (1996-11-01), None
patent: WO 97 00868 (1997-01-01), None
patent: WO 97 49702 (1997-12-01), None
patent: WO 98 09961 (1998-03-01), None
patent: 98/58901 (1998-12-01), None
patent: 99/33806 (1999-07-01), None
patent: WO 00/18761 (2000-04-01), None
patent: WO 00/50402 (2000-08-01), None
patent: 00/71129 (2000-11-01), None
patent: WO 00/64874 (2000-11-01), None
patent: WO 00 69841 (2000-11-01), None
patent: WO 01/09134 (2001-02-01), None
patent: WO 01/25220 (2001-04-01), None
patent: WO 01/38306 (2001-05-01), None
patent: WO 01/70738 (2001-09-01), None
patent: WO 02 059110 (2002-08-01), None
patent: WO 02/064096 (2002-08-01), None
patent: WO 02 074726 (2002-09-01), None
patent: WO 2004/009552 (2004-01-01), None
patent: WO 2005/061458 (2005-07-01), None
Banks, Journal of American Chemical Society, 1944, 66, p. 1131.
Chambers, R.D. et al., Academic Press, 2002, vol. 67 No. 9, pp. 1277-1284, and Database Beilstein, 2003, XP002326038.
Claverie et al., STN International (2006) HCAPLUS Database, 2006, Columbus, OH, Accession No. 1975-156364.
Gershon et al., Journal of Heterocyclic Chemistry, Jul. 1984, vol. 21 No. 4, pp. 1161-1167, XP001068813.
International Search Report from PCT/US02/01508 dated Jan. 16, 2003.
International Search Report and Written Opinion issued Aug. 1, 1995 from PCT/US2004/041068.
International Search Report issued Jan. 30, 2007 from PCT/US2006/022655.
Iwasaki, Shigeo et al., Aug. 8, 1995, Abstract, & JP 07 206789 A, XP002226238, Database Accession No. 123:285657.
Manning et al., British Journal of Pharmacology, 1999, vol. 128, pp. 1393-1398.
Martin, T.J., IDRUGS, Current Drugs Ltd. 2001, vol. 4 No. 3, pp. 312-338.
Partial International Search Report of the International Searching Authority issued Nov. 29, 2006 from PCT/US2006/022655.
PCT Written Opinion dated Jan. 28, 2005.
Registry No. 416879-93-01.
Heilman et al, “Synthesis and Antiinflammatory Evaluation of Substitued lsophthalonitriles, Trimesonitriles, Benzonitriles,and Terephthalonitriles”, Journal of Medicinal Chemistry, 1978, vol. 21, No. 9, pp. 906-913, XP-002226236.
Watanabe et al, “Structure-Activity Relationship and Rational Design of 3,4-Dephostatin Derivatives as Protein Tyrosine Phosphatase Inhibitors”, Pergamon Tetrahedron, 2000, vol. 56, pp. 741-752.
Inoue et al, “Steric Tuning in Chiral Ligand Mediated Enantioselective Alkylation of Imines”, Tetrahedron: Asymmetry, 1993, vol. 4, No. 7, pp. 1603-1606, XP002226237.
Thomas C. Mckenzie et al., “The Gomberg-Bachmann Reaction of Purines”,J. Heterocyclic Chem., May-Jun. 1987, pp. 859-861, vol. 24.
Vasu Nair et al., “Novel, Stable Congeners of Antiretroviral Compound 2′, 3′- Dideoxyadenosine,”J. Am. Chem. Soc., 1989, pp. 8502-8504, vol. III.
Vasu Nair et al., “Synthesis Of Congeners Of Adenosine Resistant To Deamination By Adenosine Deaminase,”J. Chem. Soc Comm., 1989, pp. 878-879.
James L. Kelley et al., “Synthesis and Structure- Activity Relationships of 2-Substituted-6-(dimethylamino)- 9-(4-methylbenzyl)-9H-purines with Antirhinovirus Activity,”J. Med. Chem., 1989, pp. 218-224, vol. 32.
James E. Kelley et al., “Antirhinovirus structure-activity relationships of 6-substituted-9-(4-methylbenzyl)-2-trifluoromethyl-9H-purines,”Eur. J. Med. Chem., 1990, pp. 131-135, vol. 25.
Roger J. Schilling et al., “A High-Throughput Assay For Cyclic Nucleotide Phosphodiesterases,”Analytical Biochemistry, 1994, pp. 154-158, vol. 215.
Donald V. Daniels et al., “A Semiautomated Method for the Assay of Cyclic Adenosine 5′-Monophosphate Phosphodiesterase,”Analytical Biochemistry, 1996, pp. 367-369, vol. 236.
Jean-Jacques Bourguignon et al., “9-Benzyladenines: Potent and Selective cAMP Phosphodiesterase Inhibitors,”J. Med. Chem, 1997, pp. 1768-1770, vol. 40.
James L. Kelley et al., “6-(Alkylamino)-9-alkylpurines. A New Class of Potential Antipsychotic Agents,”J. Med. Chem., 1997, pp. 3207-3216, vol. 40.
Hiroyuki Sawanishi et al., “Selective Inhibitors of Cyclic AMP-Specific Phosphodiesterase: Heterocycle-Condensed Purines”,J. Med. Chem., 1997, pp. 3248-3253, vol. 40.
J.E. Sounnes et al., “Proposal for Pharmacologically Distinct Conformers of PDE4 Cyclic AMP Phosphodiesterases”,Cell Signal, 1997, pp. 227-236. vol. 9, No. 3-4.
Mary Elizabeth Bach

Affiliated with

Also associated with

Rating

Phosphodiesterase 4 inhibitors, including aminoindazole and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phosphodiesterase 4 inhibitors, including aminoindazole and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphodiesterase 4 inhibitors, including aminoindazole and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4152000